Krista Eschbach
Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistant Epilepsy | 25 | 2026 | 145 | 5.750 |
Why?
| | Status Epilepticus | 17 | 2026 | 71 | 5.170 |
Why?
| | Epilepsy | 16 | 2026 | 400 | 2.650 |
Why?
| | Epilepsies, Myoclonic | 4 | 2020 | 63 | 1.700 |
Why?
| | Seizures, Febrile | 5 | 2025 | 23 | 1.460 |
Why?
| | Anticonvulsants | 7 | 2026 | 253 | 1.080 |
Why?
| | Neurosurgical Procedures | 6 | 2026 | 209 | 1.060 |
Why?
| | Electroencephalography | 11 | 2026 | 576 | 0.940 |
Why?
| | Seizures | 13 | 2026 | 489 | 0.830 |
Why?
| | Neuropsychological Tests | 2 | 2026 | 1149 | 0.820 |
Why?
| | Gastrointestinal Diseases | 1 | 2025 | 220 | 0.760 |
Why?
| | Developmental Disabilities | 3 | 2026 | 281 | 0.730 |
Why?
| | Referral and Consultation | 2 | 2026 | 881 | 0.730 |
Why?
| | Neurology | 1 | 2021 | 107 | 0.610 |
Why?
| | Dioxolanes | 1 | 2019 | 6 | 0.590 |
Why?
| | Patient Admission | 1 | 2021 | 216 | 0.580 |
Why?
| | Child | 34 | 2026 | 22693 | 0.580 |
Why?
| | Child, Preschool | 24 | 2026 | 11913 | 0.540 |
Why?
| | Brain Waves | 1 | 2018 | 45 | 0.540 |
Why?
| | Nervous System Diseases | 1 | 2021 | 288 | 0.530 |
Why?
| | Patient Safety | 1 | 2021 | 352 | 0.520 |
Why?
| | Quality of Life | 5 | 2025 | 3200 | 0.510 |
Why?
| | Thyrotropin | 1 | 2017 | 120 | 0.500 |
Why?
| | Epileptic Syndromes | 4 | 2024 | 98 | 0.470 |
Why?
| | Caregivers | 1 | 2024 | 1080 | 0.450 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 320 | 0.440 |
Why?
| | Infant | 16 | 2026 | 10114 | 0.430 |
Why?
| | Adolescent | 23 | 2026 | 22557 | 0.420 |
Why?
| | Diet, Ketogenic | 3 | 2024 | 40 | 0.400 |
Why?
| | Palliative Care | 4 | 2026 | 1032 | 0.400 |
Why?
| | Testosterone | 1 | 2017 | 419 | 0.390 |
Why?
| | Encephalitis | 3 | 2026 | 143 | 0.390 |
Why?
| | Telemedicine | 1 | 2021 | 966 | 0.340 |
Why?
| | Male | 29 | 2026 | 73396 | 0.340 |
Why?
| | Humans | 45 | 2026 | 146342 | 0.330 |
Why?
| | Female | 30 | 2026 | 79499 | 0.330 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 2363 | 0.280 |
Why?
| | Corpus Callosum | 2 | 2026 | 76 | 0.280 |
Why?
| | Young Adult | 12 | 2026 | 14330 | 0.270 |
Why?
| | Cytokines | 2 | 2026 | 2081 | 0.260 |
Why?
| | Registries | 3 | 2025 | 2400 | 0.250 |
Why?
| | Time-to-Treatment | 2 | 2026 | 257 | 0.240 |
Why?
| | Delayed Diagnosis | 1 | 2026 | 102 | 0.230 |
Why?
| | Syndrome | 1 | 2026 | 380 | 0.220 |
Why?
| | Treatment Outcome | 12 | 2026 | 11821 | 0.220 |
Why?
| | Retrospective Studies | 11 | 2026 | 17438 | 0.210 |
Why?
| | Prodromal Symptoms | 1 | 2025 | 20 | 0.210 |
Why?
| | Middle Aged | 13 | 2026 | 36619 | 0.200 |
Why?
| | Psychosurgery | 1 | 2023 | 9 | 0.200 |
Why?
| | Databases, Factual | 3 | 2024 | 1493 | 0.200 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 104 | 0.200 |
Why?
| | Adult | 14 | 2026 | 41087 | 0.200 |
Why?
| | Intralaminar Thalamic Nuclei | 1 | 2024 | 22 | 0.200 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 253 | 0.190 |
Why?
| | Immunotherapy | 2 | 2025 | 671 | 0.180 |
Why?
| | Fever | 1 | 2024 | 322 | 0.180 |
Why?
| | Neurodevelopmental Disorders | 1 | 2026 | 239 | 0.180 |
Why?
| | Genetic Testing | 2 | 2022 | 492 | 0.180 |
Why?
| | Laser Therapy | 1 | 2023 | 146 | 0.170 |
Why?
| | Cross-Sectional Studies | 6 | 2026 | 5899 | 0.170 |
Why?
| | GABA Modulators | 1 | 2021 | 11 | 0.170 |
Why?
| | Cognition Disorders | 1 | 2026 | 559 | 0.170 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 2 | 2019 | 25 | 0.170 |
Why?
| | Brain Injuries | 1 | 2026 | 499 | 0.160 |
Why?
| | Interviews as Topic | 1 | 2024 | 930 | 0.160 |
Why?
| | Deep Brain Stimulation | 1 | 2024 | 223 | 0.160 |
Why?
| | Spasms, Infantile | 1 | 2021 | 138 | 0.150 |
Why?
| | Cerebral Palsy | 1 | 2022 | 149 | 0.150 |
Why?
| | Cohort Studies | 5 | 2026 | 6077 | 0.150 |
Why?
| | Follow-Up Studies | 2 | 2026 | 5439 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2026 | 733 | 0.140 |
Why?
| | Drug Approval | 1 | 2019 | 94 | 0.140 |
Why?
| | Surveys and Questionnaires | 3 | 2026 | 6073 | 0.140 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2018 | 21 | 0.140 |
Why?
| | Communication | 1 | 2024 | 980 | 0.130 |
Why?
| | Pediatrics | 1 | 2026 | 1124 | 0.130 |
Why?
| | Body Height | 1 | 2017 | 205 | 0.120 |
Why?
| | Neurofilament Proteins | 2 | 2026 | 83 | 0.110 |
Why?
| | Inflammation | 1 | 2025 | 2919 | 0.100 |
Why?
| | Body Weight | 1 | 2017 | 968 | 0.100 |
Why?
| | Mutation | 3 | 2021 | 4093 | 0.090 |
Why?
| | Aged | 7 | 2026 | 26432 | 0.090 |
Why?
| | Quality Improvement | 1 | 2021 | 1354 | 0.090 |
Why?
| | Prospective Studies | 4 | 2026 | 8123 | 0.090 |
Why?
| | United States | 2 | 2026 | 16136 | 0.080 |
Why?
| | Prognosis | 2 | 2026 | 4351 | 0.060 |
Why?
| | Infant, Newborn | 3 | 2024 | 6460 | 0.060 |
Why?
| | Risk Factors | 1 | 2021 | 10921 | 0.060 |
Why?
| | S100 Calcium Binding Protein beta Subunit | 1 | 2026 | 9 | 0.060 |
Why?
| | Blood Cell Count | 1 | 2025 | 56 | 0.060 |
Why?
| | Time Factors | 2 | 2026 | 7109 | 0.050 |
Why?
| | Atrophy | 1 | 2025 | 199 | 0.050 |
Why?
| | Biomarkers | 2 | 2026 | 4340 | 0.050 |
Why?
| | Florida | 1 | 2024 | 117 | 0.050 |
Why?
| | Rituximab | 1 | 2024 | 208 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 219 | 0.050 |
Why?
| | Probability | 1 | 2023 | 309 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3926 | 0.040 |
Why?
| | Subdural Space | 1 | 2021 | 7 | 0.040 |
Why?
| | Stereotaxic Techniques | 1 | 2021 | 42 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2026 | 317 | 0.040 |
Why?
| | Preoperative Care | 1 | 2024 | 396 | 0.040 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 145 | 0.040 |
Why?
| | Infectious Encephalitis | 1 | 2020 | 3 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 307 | 0.040 |
Why?
| | Electrodes, Implanted | 1 | 2021 | 114 | 0.040 |
Why?
| | Valproic Acid | 1 | 2020 | 45 | 0.040 |
Why?
| | Potassium Channels | 1 | 2021 | 149 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2021 | 43 | 0.040 |
Why?
| | Animals | 2 | 2021 | 38107 | 0.040 |
Why?
| | Internet | 1 | 2025 | 660 | 0.040 |
Why?
| | Disease Management | 1 | 2024 | 651 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 2113 | 0.040 |
Why?
| | Family | 1 | 2024 | 690 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 597 | 0.040 |
Why?
| | DNA Polymerase gamma | 1 | 2019 | 8 | 0.040 |
Why?
| | Cannabinoids | 1 | 2021 | 182 | 0.040 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2019 | 38 | 0.040 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 49 | 0.040 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2019 | 43 | 0.040 |
Why?
| | Cannabidiol | 1 | 2021 | 142 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2024 | 992 | 0.030 |
Why?
| | Family Health | 1 | 2019 | 194 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2021 | 442 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 2019 | 138 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 221 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3347 | 0.030 |
Why?
| | Anxiety | 1 | 2025 | 1125 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1064 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 597 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 3206 | 0.020 |
Why?
| | Brain | 1 | 2025 | 2991 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1468 | 0.020 |
Why?
|
|
Eschbach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|